Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.

A, Maruani; E, Tavernier; O, Boccara; J, Mazereeuw-Hautier; S, Leducq; D, Bessis; L, Guibaud; P, Vabres; V, Carmignac; S, Mallet; S, Barbarot; C, Chiaverini; C, Droitcourt; AC, Bursztejn; C, Lengellé; JB, Woillard; D, Herbreteau; Touze A, Le; A, Joly; C, Léauté-Labrèze; J, Powell; H, Bourgoin; V, Gissot; B, Giraudeau; B, Morel

doi:10.1001/jamadermatol.2021.3459

Public

Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.

Shared by NobleBlocks on Nov 1, 2021 • 12:00 AM UTC

Authors:

Maruani A

Tavernier E

Boccara O

Abstract

Importance Sirolimus is increasingly being used to treat various vascular anomalies, although evidence of its efficacy is lacking.Objective To assess the efficacy and safety of sirolimus for children with slow-flow vascular malformations to better delineate the indications for treatment.Design, sett...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!